Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Femasys Inc. stock logo
FEMY
Femasys
$0.96
+3.8%
$0.98
$0.69
$1.80
$30.74M-2.56264,233 shs245,215 shs
Fonar Corporation stock logo
FONR
Fonar
$15.55
-0.3%
$13.98
$12.00
$18.68
$95.39M117,338 shs5,072 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.50
+0.6%
$2.55
$0.82
$3.38
$90.77M1.131.77 million shs540,417 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$88.20
+3.4%
$78.33
$41.50
$90.32
$4.45B-2.63793,651 shs1.03 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Femasys Inc. stock logo
FEMY
Femasys
-1.00%-1.86%+15.00%-22.03%-19.30%
Fonar Corporation stock logo
FONR
Fonar
+0.84%-0.19%+7.67%+24.12%-2.93%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-1.20%-0.40%-11.74%+50.30%+129.63%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-0.01%+3.18%+12.91%+34.76%+101.04%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Femasys Inc. stock logo
FEMY
Femasys
3.7062 of 5 stars
3.55.00.00.03.32.50.6
Fonar Corporation stock logo
FONR
Fonar
1.2473 of 5 stars
0.03.00.00.01.80.81.9
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.1769 of 5 stars
3.52.00.00.03.10.00.6
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4.7235 of 5 stars
4.52.00.04.62.72.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Femasys Inc. stock logo
FEMY
Femasys
3.00
Buy$8.67807.50% Upside
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00260.72% Upside
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.09
Buy$107.1021.44% Upside

Current Analyst Ratings Breakdown

Latest FEMY, SLNO, FONR, and MBOT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$110.00
6/11/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
5/13/2025
Femasys Inc. stock logo
FEMY
Femasys
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $6.00
5/9/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
5/8/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$81.00 ➝ $97.00
5/8/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$102.00 ➝ $105.00
4/24/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$93.00 ➝ $145.00
4/15/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$100.00 ➝ $100.00
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Femasys Inc. stock logo
FEMY
Femasys
$1.63M19.06N/AN/A$0.10 per share9.55
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.94$3.10 per share5.02$24.78 per share0.63
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.17 per shareN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.68 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Femasys Inc. stock logo
FEMY
Femasys
-$18.82M-$0.91N/AN/AN/A-1,242.06%-392.45%-137.15%8/14/2025 (Estimated)
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2512.31N/A8.19%5.31%3.97%9/25/2025 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$175.85M-$4.62N/AN/AN/AN/A-77.52%-63.44%8/6/2025 (Estimated)

Latest FEMY, SLNO, FONR, and MBOT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$0.85N/AN/AN/A$3.91 millionN/A
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/8/2025Q1 2025
Femasys Inc. stock logo
FEMY
Femasys
-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 million
5/7/2025Q1 2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$1.14-$0.95+$0.19-$0.95N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Femasys Inc. stock logo
FEMY
Femasys
N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Femasys Inc. stock logo
FEMY
Femasys
0.02
0.93
0.54
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
16.19
16.19
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.21
19.64
19.64

Institutional Ownership

CompanyInstitutional Ownership
Femasys Inc. stock logo
FEMY
Femasys
65.27%
Fonar Corporation stock logo
FONR
Fonar
50.64%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%

Insider Ownership

CompanyInsider Ownership
Femasys Inc. stock logo
FEMY
Femasys
11.54%
Fonar Corporation stock logo
FONR
Fonar
1.55%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
6.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Femasys Inc. stock logo
FEMY
Femasys
3032.53 million22.60 millionNot Optionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million34.65 millionOptionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3050.39 million47.17 millionOptionable

Recent News About These Companies

SLNO Soleno Therapeutics, Inc. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Femasys stock logo

Femasys NASDAQ:FEMY

$0.96 +0.04 (+3.80%)
As of 02:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Fonar stock logo

Fonar NASDAQ:FONR

$15.54 -0.05 (-0.29%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.50 +0.02 (+0.60%)
As of 02:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Soleno Therapeutics stock logo

Soleno Therapeutics NASDAQ:SLNO

$88.20 +2.94 (+3.44%)
As of 02:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.